Delivery Order SPE2DB25D3110-SPE2DB25FTDSL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,247.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 16, 2025, with completion scheduled for July 17, 2025. This competitive, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $5,859.08. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,893.98 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 packs) on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,049.32 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,419.07 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on August 1, 2025. This firm fixed-price delivery order, which is part of a non-set-aside competitive procurement, is scheduled for completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,277.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a ceiling value of $12,688.65. This firm fixed-price delivery order, which is expected to be completed by September 18, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $13,515.86 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTDSLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $14,675.36. This firm fixed-price delivery order, awarded on June 30, 2025, with a completion date of July 1, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare programs worldwide. The contract vehicle supports multiple therapeutic domains and serves customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor within DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 6/30/25 |